Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azienda Farmaceutica Italiana (AFI) is an Italian pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) headquartered in Cura Carpignano. The company specializes in the development, production, and primary and secondary packaging of medicinal products, medical devices, and food supplements. AFI offers a wide range of manufacturing capabilities, including the production of solid, liquid, and semi-solid dosage forms such as tablets, capsules, syrups, and creams. As a CDMO, the company provides comprehensive services to international pharmaceutical partners, supporting them from the initial formulation stages through to large-scale commercial production. The facility is GMP-certified, ensuring high quality standards and compliance with European regulatory requirements. In addition to its contract services, AFI maintains its own portfolio of healthcare products focused on therapeutic areas like gastroenterology and respiratory health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azienda Farmaceutica Italiana.